Showing results (131-140 of 150) with videos related to
Sort By:
Pageof 15
Diabetic Medicine : a Journal of the British Diabetic Association|May 25, 2004
Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitusN H Kim, K B Kim, D L Kim, et al.BMC Medical Genetics|March 10, 2011
Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control studyMarieke Emonts, Mieke J M W Hazes, Jeanine J Houwing-Duistermaat, et al.European Review for Medical and Pharmacological Sciences|October 4, 2021
Hypocomplementemia (C3) as an independent predictor for children with acute post-streptococcal glomerulonephritis: a long-term observationK H Han, K H Lee, S J Park, et al.Annals of the Rheumatic Diseases|July 24, 2007
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.Endocrinology|July 5, 2013
Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db miceH W Kim, J E Lee, J J Cha, et al.Alimentary Pharmacology & Therapeutics|March 10, 2018
Responses are durable for up to 5 years after completion of peginterferon alfa-2a treatment in hepatitis B e antigen-positive patientsW-L Chuang, J Jia, H L Y Chan, et al.Gut|February 10, 2009
Celecoxib induces hepatic stellate cell apoptosis through inhibition of Akt activation and suppresses hepatic fibrosis in ratsY-H Paik, J K Kim, J I Lee, et al.Alimentary Pharmacology & Therapeutics|March 2, 2018
Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillanceY E Chon, K S Jung, M-J Kim, et al.Endocrinology|January 12, 2012
Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db miceD H Nam, M H Lee, J E Kim, et al.Hepatology (Baltimore, Md.)|November 3, 2011
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or CY-F Liaw, J-D Jia, H L Y Chan, et al.Pageof 15